Satsuma Pharmaceuticals, Inc.
0 followers
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-admi... Read more
Org chart
Dave Prichard
Vice President And Head Of Manufacturing
Mic Iwashima
Vice President and Head of Operations
Rob Schultz
Senior Vice President amd Head of CMC
Shannon Strom
Vice President and Head of Regulatory Affairs
Alexander Majeska, PMP
Senior Manager of Medical Device Engineering
Diana Sayre
Senior Director Of Accounting
